Mendor has raised €8.1 million in a series-B venture capital financing round. The Finnish provider of diabetes technologies and services will use the funding to facilitate its global market expansion.

The financing round was headed by Finnish investor and entrepreneur Risto Siilasmaa. Other investors were Life Science Partners, Risto Siilasmaa, Finnish Industry Investment, Ilmarinen, Biothom and Finnvera Venture Capital.

Click here for the release from PR Newswire.